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Nucleophosmin (NPM) is a nucleolar protein involved in ribosome biogenesis. NPM1 gene is
frequently mutated in acute myeloid leukaemia (AML), correlating with aberrant cytoplasmic local-
ization of the protein. NPM attachment to the nucleolus in physiological conditions probably
depends on binding to nucleic acids, and this recognition could be altered in AML. NPM associates
to guanine-rich DNA sequences, able to fold as ‘‘G-quadruplexes’’. We have analyzed the interaction
of pentameric, full length NPM with G-rich oligonucleotides, ﬁnding that the protein binds prefer-
entially high-order G-quadruplexes. AML-associated mutation signiﬁcantly hampers DNA binding,
pointing to a possible mechanism contributing to pathological mislocalization of NPM.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Nucleophosmin (NPM, also termed NPM1, B23, NO38 or numa-
trin) is a nuclear chaperone mainly located in the nucleoli of cells.
NPM performs several functions affecting cell growth: it is in-
volved in ribosome assembly and export from the nucleolus to
the cytoplasm; it controls centrosome duplication, and regulates
the stability of tumor suppressors, such as p53 and Arf [1]. The
multiple activities of NPM have an impact on both proliferation
and apoptosis, and not surprisingly, NPM deregulation has been in-
volved in several human cancers [2]. NPM is a 294 aminoacid pro-
tein, apparently pentameric in solution, and constituted by several
domains. The core domain, corresponding to the ﬁrst 120 aminoac-
ids, folds into a b-structure, and is responsible for the oligomeriza-
tion, forming a ring with pentameric symmetry [3]. The core is
connected to a small C-terminal domain, built of 3 a-helices [4]
through a long and ﬂexible linker.
Although enriched in nucleoli, NPM is a ‘‘shuttling protein’’, its
functionality requiring a continuous transit between cytoplasm,
nucleoplasm and nucleolus. These transport events rely on thepresence of different localization signals in NPM: nuclear localiza-
tion (NLS), nuclear export (NES) and nucleolar localization signals
(NoLS) [1,5]. As for nucleolar targeting, it has been described that
two Trp residues in the C-terminal region of the protein are neces-
sary for the attachment of NPM to that particular subnuclear re-
gion [6]. When the 3D structure of NPM C-terminal domain was
solved [4], it was evident that those residues are essential for pack-
ing of the hydrophobic core of the domain. Therefore, a more pre-
cise view is that nucleolar localization depends on the proper
folding of that domain, and probably, on its binding to nucleolar li-
gands (either proteins or nucleic acids), as it has been proposed for
other nucleolar proteins [7].
NPM is the most frequently mutated protein in acute myeloid
leukaemia (AML), constituting a hallmark of a particular subtype
of the disease [8]. Mutant NPM is mainly found in the cytoplasm
rather than in nucleoli of leukoblasts from these AML patients
[9]. The genetic lesion implicated in AML consists in the insertion
of four bases in the NPM gene, causing a frameshift that gives rise
to a mutant NPM with a different C-terminal aminoacid sequence
[9]. This alteration implies the loss of the two conserved Trp
residues that had been related to nucleolar localization. In fact, it
was shown that the lack of these aromatic residues prevents
folding of the domain, and this, in turn, results in a failure of nucle-
olar retention [4]. Additionally, the novel sequence contains a NES,
and both features of mutant NPM (loss of the Trp residues and
acquirement of the new NES) contribute to determine the aberrant
S. Bañuelos et al. / FEBS Letters 587 (2013) 2254–2259 2255localization of AML-related mutant NPM to the cytoplasm instead
of the nucleolus [10].
NPM binds numerous proteins [1] as well as DNA and RNA [11].
The nucleic acid binding ability of the protein has been ascribed to
its C-terminal 70 residues, e.g., the C-terminal globular domain plus
a previous segment of 20 residues, including several lysines [11].
Although NPM was initially described to associate with DNA in a
rather unspeciﬁc manner [11], it has been more recently reported
to preferentially recognize guanine rich sequences that are able to
form particular DNA structures known as ‘‘G-quadruplex’’ (G4)
[12]. These are four stranded motifs, where at least 2 planar groups
of guanines (‘‘G-tetrad’’) pile on top of each other, stabilized by
‘‘Hoogsteen type’’ hydrogen bonds and monovalent cations [13].
These structures, different from the canonical double helix, are
thought to exist in vivo, and play a role in telomere maintenance
and transcriptional regulation [14]. G-quadruplexes can be either in-
tra (in a sequence with at least four tracks of three or more G) or
intermolecular (bridging two or more strands), and each type can
display different conﬁgurations [13]. One of the most studied G-
quadruplex forming DNA is a sequence of the c-Myc oncogene pro-
moter region, the nuclease hypersensitivity element III1 (NHEIII1).
There is evidence that formation of a G-quadruplex by this sequence
controls 80–90% of the transcription level of c-Myc. This DNA struc-
ture, therefore, may represent a valid target for cancer therapy [14].
Brunori et al. have described that NPM C-terminal region binds
the G-rich DNA sequence (c-MYC III1) from the c-Myc promoter
and other G-rich sequences that also form G-quadruplexes [12].
Recently they have presented a structural model based on NMR
of the C-terminal domain of NPM (‘‘NPM1-C70’’, including the up-
stream extension) bound to a sequence derived from c-Myc [15].
The interaction of the protein with G-rich sequences needs to be
further investigated to better understand the determinants of
NPM localization and functionality. Here, we have explored the
interaction of full length, oligomeric NPM with different types of
G-quadruplex forming oligonucleotides. We found that NPM binds
high-order (intermolecular) G4 structures with higher afﬁnity than
the monomeric intramolecular G-quadruplex previously described
[15]. Furthermore, we have evaluated the consequences of patho-
logical mutations of NPM on its DNA binding properties. Our data
show that the DNA binding ability of a leukaemia-related full
length mutant NPM is drastically reduced, in agreement with re-
cently published data on the binding deﬁciency of the mutated
C-terminal domain [16]. Therefore, alterations in nucleic acid rec-
ognition are strongly suggested to contribute to the aberrant cyto-
plasmic localization of NPM characteristic of AML.
2. Materials and methods
2.1. DNA oligonucleotides
Oligonucleotides G4MYC (50-TGGGGAGGGTGGGGAGGGTGGG-
GAAGG) [12], G4Pu22 (50-TGAGGGTGGGTAGGGTGGGTAA) [17],
and G4Pu24I (50-TGAGGGTGGIGAGGGTGGGGAAGG) [15] (pur-
chased from GenScript USA Inc) are related to the c-Myc promoter
sequence. To facilitate G-quadruplex formation, the oligonucleo-
tides were resuspended in 20 mM Hepes, 100 mM KCl, pH 7.5
and annealed by heating at 95 C for 5 min, and slowly cooling
down at room temperature overnight. For some experiments, the
DNA samples were resuspended without KCl and/or not subjected
to annealing. Oligo G4tetra (50-TCGCCACGTTTCGCCGTTTGCGGG
GGTTTCTGCGAGGAACTTTGG) [18] (from Sigma–Aldrich) was an-
nealed as described in Ref. [18].
2.2. Protein production
Full length NPM, both wild type and the AML-associated mutant
A [9] were cloned in the plasmid pET8c-6HTEV [19], using as tem-plate a clone of human NPM kindly provided by Dr. Zhang [20].
Both constructs carry an N-terminal (His)6 tag. Proteins were ex-
pressed overnight at 18 C in Escherichia coli, BL21 (DE3) strain.
For puriﬁcation, cells were disrupted by sonication in 25 mM
Tris/HCl, pH 7.5, 0.5 M NaCl, 20 mM imidazole, 5 mM MgCl2,
1 mM TCEP, 10% glycerol, supplemented with lysozyme (20 mg/L
culture) and protease inhibitors (Complete, EDTA-free, Roche).
The clariﬁed extract was loaded on a Ni–NTA afﬁnity column (Hi-
strap FF, GE Healthcare) and the protein eluted with an imidazole
gradient. NPM was then further puriﬁed by gel ﬁltration chroma-
tography with Superdex 200 (GE Healthcare) in 25 mM Tris pH
7.5, 100 mM NaCl, 1 mM DTT, 10% glycerol, concentrated and fro-
zen for storage. We have observed a small proportion of degrada-
tion products in mutant A, being at most 13% as estimated by
densitometry of SDS–PAGE.
2.3. Electrophoretic mobility shift assays (EMSA)
Binding assays were performed titrating either a ﬁxed amount
of NPM with increasing concentrations of oligonucleotide or vice
versa. Binding reactions (20 lL) containing the appropriate
amounts of NPM and DNA were incubated for 1 h at room temper-
ature in 20 mM Hepes, 100 mM KCl, 2 mM TCEP, 10% glycerol, pH
7.5 (‘‘Hepes/K buffer’’), and loaded onto 8.5% polyacrylamide native
gels. Electrophoresis was run at 120 V at room temperature, in
0.5 TBE buffer. Gels were stained with GelRed (Biotium) for
DNA detection and with Coomassie afterwards. For quantiﬁcation,
the ﬂuorescence intensity of the band corresponding to the com-
plex was measured with a GelDoc EZ Imager and Image Lab soft-
ware (Bio-Rad).
2.4. Size exclusion chromatography (SEC)
Mixtures of NPM and DNA (or either protein or DNA alone, as
controls) were incubated for 1 h at room temperature in Hepes/K
buffer. Then, 25 lL were injected in a Superdex 200 PC 3.2/30 col-
umn (GE), equilibrated in the same buffer, and chromatography
was run at 4 C.
2.5. Isothermal titration calorimetry (ITC)
ITC measurements were carried out using a VIP-ITC MicroCalo-
rimeter (MicroCal, Inc., Northampton, MA), at 20 C. Protein and
DNA were dialyzed against Hepes/K buffer, and degassed prior to
the experiment. Oligonucleotides, at 200–250 lM, were titrated
onto NPM at 2–4 lM. Injections of 10 lL were performed at
240 s interval. The reaction heat of each injection is related to
the calorimetric enthalpy of binding, DH. The binding isotherms,
DH cursive vs. molar ratio, were analysed with an independent
binding sites model using MicroCal Origin software. The ﬁt of the
binding curve yields the binding constant Ka (Kd = 1/Ka), the enthal-
py DH and the stoichiometry of the binding reaction.
3. Results
We have characterized the interaction of full length NPM with
the sequence 50-TGGGGAGGGTGGGGAGGGTGGGGAAGG-30 from
c-Myc promoter (hereby termed G4MYC). The DNA oligo was sub-
jected to annealing in the presence of K+ ions to promote G-quad-
ruplex (G4) structures formation. We followed the binding process
by electrophoretic mobility shift assays (EMSA) (Fig. 1): When
NPM is mixed with G4MYC, a fraction of the DNA co-migrates with
the protein. Both the DNA and protein staining reﬂect the forma-
tion of a complex of larger size than the protein alone (Fig. 1A).
Semiquantitative binding curves obtained from EMSA gels by den-
sitometric analysis show that the amount of slowly migrating DNA
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Fig. 1. Binding of NPM to G4MYC. (A) EMSA gel showing migration of increasing
amounts (0–100 lM) of G4MYC in the presence of 5 lM NPM. The position of the
NPM/DNA complex is indicated by an asterisk. The right lane (‘‘C’’) corresponds to
100 lM G4MYC without protein, as control. The same gel was stained with GelRed
to visualize DNA (top) and Coomassie to visualize protein (bottom). (B) Binding
curve representing the relative ﬂuorescence intensity of DNA in the complex as a
function of G4MYC:NPM (pentamer) molar ratio.
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Fig. 2. Size exclusion chromatography of G4MYC and a mixture of G4MYC and
NPM. (A) Elution proﬁle of 10 lMG4MYC in Hepes/K buffer, annealed (red line), not
annealed (black, solid), and in the same buffer but without KCl, not annealed (black,
dashed). The peak corresponding to monomeric G4 is indicated with an arrow. (B)
Chromatogram of a mixture of 50 lM G4MYC (annealed) and 10 lM NPM
(continuous lines), together with the proﬁles of DNA alone (red, discontinuous)
and protein alone (blue, discontinuous). Registers at 254 nm are in red and 280 nm
in blue. The peak corresponding to the protein/DNA complex is marked with an
asterisk.
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G4MYC:NPM pentamer molar ratio of approximately 10 (Fig. 1B).
It should be noted that free G4MYC does not run as a population
of deﬁned size but rather displays a diffuse migration. G4MYC be-
haved, indeed, as a mixture of populations of different sizes when
analyzed through size exclusion chromatography (SEC) (Fig. 2). By
comparing the chromatographic proﬁles of G4MYC in the presence
and absence of KCl, and either annealed or not annealed, the last
eluting (Ve 16.5 mL) component could be attributed to monomeric
G4, whereas the bigger species (e.g. eluting before) would corre-
spond to oligomeric forms of G4MYC, that are concentration-
dependent (compare 10 and 50 lM G4MYC in Fig. 2 panels A and
B). Therefore, both EMSA and chromatography reﬂect that, in our
conditions, G4MYC may form structures of different sizes and
properties. This is in line with previous reports describing the
structural heterogeneity of c-MYC sequence [13,21].
A mixture of NPM and G4MYC in 1:5 molar ratio, analyzed by
SEC, reveals, in agreement with EMSA results, the formation of acomplex of bigger size than NPM alone, and containing signiﬁcant
amounts of DNA, as evident from the comparison of 254 and
280 nm registers (Fig. 2B). The decrease in relative amount of lar-
ger size species, together with the similar intensity of the compo-
nent eluting at 16.5 mL in the elution proﬁle of the NPM/G4MYC
mixture as compared with that of G4MYC alone, suggest a prefer-
ential binding of the protein to G4MYC oligomers rather than
monomeric, intramolecular G4.
In an attempt to further characterize the binding of NPM to
G4MYC we have analyzed it by isothermal titration calorimetry
(ITC). Fig. 3 shows the exothermic binding response of NPM ti-
trated with G4MYC. Fitting of the isotherm with a binding model
that considers identical, independent sites, renders the binding
parameters indicated in the ﬁgure. The measured G4MYC binding
afﬁnity to the full length protein (3.8 lM) is similar to that deter-
mined for the isolated C-terminal region by means of SPR (NPM1-
C70, 1.9 lM [12]) and strongly suggests that the rest of the protein
does not signiﬁcantly modulate the binding. The observed stoichi-
ometry of 4.3, on the other hand, reveals that all of the ﬁve poten-
tial binding sites in pentameric NPM can associate with DNA. The
binding process is favoured both enthalpically (DH = 2.13 kcal/
mol) and entropically (TDS = 5.13 kcal/mol).
We have performed titration experiments at different tempera-
tures, in the range from 10 to 40 C, and determined a change
in heat capacity, Dcp (estimated from the linear ﬁt of DH vs.
Fig. 3. Isothermal titration of NPM with G4MYC. The upper panel shows the base
line corrected instrumental response of successive additions of G4MYC (200 lM) to
NPM (2 lM, pentamer), at 20 C; the lower panel shows the integrated data (solid
squares) and the ﬁt of the binding isotherm by an independent binding sites model
(line). The obtained thermodynamical parameters are indicated.
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S. Bañuelos et al. / FEBS Letters 587 (2013) 2254–2259 2257temperature) of 85 ± 13 cal mol1 K1, associated with the interac-
tion between NPM and G4MYC. This parameter has been described
to depend on the balance between polar and non-polar buried sol-
vent accessible areas of the interacting molecules [22]. By contrast
to the more common negative Dcp in most protein–protein com-
plexes, dominated by the hydrophobic effect, our obtained small,
positive value suggests that the interaction involves a mainly polar
interface, in agreement with the structural study of NPM C-termi-
nal domain bound to a G-quadruplex [15], where from the buried
accessible surface areas, a Dcp of +25 cal mol1 K1 can be pre-
dicted. On the other hand, since Dcp is related to DSsolv (solvation
entropy), decomposition ofDS [22], reveals a favorableDSconf (con-
formational entropy), suggesting that NPM interaction with
G4MYC involves some conformational rearrangement. While there
is no evidence of conformational changes upon binding of a G-
quadruplex to NPM C-terminal domain [15], they cannot be ex-
cluded in the case of the full length protein.
To circumvent the difﬁculties posed by the heterogeneity of
G4MYC, we have tested the interaction of NPM with variants of
c-MYC DNA sequence, which were described to fold into unique
G-quadruplex conformations (G4Pu22 [17] and G4Pu24I [15]).
None of them bound signiﬁcantly to NPM, as seen either by EMSA
(shown in Fig. 4A for G4Pu24I) or SEC (shown in Fig. 4B for
G4Pu22), under conditions where complex formation of NPM with
G4MYC can be readily observed, or in the presence of ﬁvefold high-
er NPM concentration. An ITC titration of G4Pu24I onto NPM, in thesame conditions as with G4MYC, showed no detectable binding but
only dilution heat (not shown). Altogether, these results further
suggest that NPM may bind intermolecular G4 conformations with
higher avidity than monomeric G4 structures. Although by NMR it
has been clearly stated that NPM can bind G4Pu24I [15], our data
indicate that the binding afﬁnity must be much lower than for
G4MYC.
To know whether NPM can also recognize intermolecular G-
quadruplexes, we have explored its interaction with a DNA se-
quence (‘‘G4tetra’’), as a model of tetrameric, but not intramolecu-
lar G4 [18]. When mixtures of NPM and G4tetra were analyzed by
SEC (Fig. 4C), no signiﬁcant binding was observed at concentrations
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Fig. 5. Effect of AML-linked mutation on the DNA binding ability of full length NPM.
(A) EMSA gel of increasing amounts of G4MYC in the presence of 5 lMmutant A, to
be compared with Fig. 1A. (B) Densitometric analysis of EMSA assays: Relative
ﬂuorescence of G4MYC bound to wild type NPM (solid circles), or mutant A (open
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line), as compared with G4MYC/wild type NPM (dashed line) and G4MYC alone
(dashed–dotted line).
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G4tetra complex appeared at ﬁvefold NPM concentration. This re-
sult indicates that, although the afﬁnity of NPM for G4tetra is
weaker than for G4MYC, the protein is able to recognize a tetra-
meric G4 species. We have conﬁrmed, through EMSA experiments,
that NPM binds oligo G4tetra saturably but with weaker afﬁnity
than G4MYC (Fig. 4A). In spite of the semi-quantitative nature of
this assay, the binding curve allows Kd to be grossly estimated as
30–40 lM, e.g., one order of magnitude weaker. Unfortunately,
the high amounts of both protein and DNA that would be required
(several fold higher than those used in the ITC titration of NPM
with G4MYC) prevented us from thermodynamically characteriz-
ing the interaction with G4tetra.
NPM is frequently mutated in acute myeloid leukaemia (AML).
The genetic alterations, which correlate with aberrant cytoplasmic
localization of NPM, affect the C-terminal domain, e.g., the DNA
binding region of the protein. We hypothesized that AML-related
mutations might affect the DNA recognition by NPM, and indeed,
it has been very recently published that the mutations abolish
the ability of NPM C-terminal domain to bind G-quadruplex form-
ing oligonucleotides [16]. In order to further explore this possibil-
ity in full length NPM, we have produced a recombinant NPM
bearing the mutation most commonly found in AML patients
(‘‘Mutant A’’ [9]). By contrast to wild type NPM, the mutant does
not show helical secondary structure, as judged by circular dichro-
ism, nor any cooperative thermal transition in its ellipticity mea-
sured at 222 nm (not shown). This observation indicates that, in
agreement with what was previously described for the isolated
C-terminal domain [4], the mutation severely damages the struc-
ture of this helical domain, in the context of the full length protein.
Mutant NPM displayed a signiﬁcantly reduced ability to bind
G4MYC, as shown in Fig. 5. Binding curves obtained from EMSA
experiments show that the amount of DNA bound by the mutant
is less than 20% of that bound by wild type NPM, at equivalent
G4MYC: NPM molar ratios (Fig. 5B). Although, probably due to the
lack of structure of the C-terminal domain, our mutant preparation
suffers some proteolysis, we have estimated that this degradation
accounts for, at most, 13% of the protein. Furthermore, through mass
spectrometry analysis, a major protein species is detected, with a
size corresponding to the full length construct (not shown). There-
fore, the minor degradation suffered by mutant NPM cannot explain
the strong reduction in afﬁnity for DNA. Further supporting this re-
sult, gel ﬁltration chromatography also reﬂects that a complex is
formed between G4MYC and mutant NPM, but with much lower
yield than in the case of wild type NPM (Fig. 5C).
4. Discussion
NPM interaction with nucleic acids is probably crucial for sev-
eral of its functions, especially for its role in ribosome biogenesis.
Furthermore, this molecular recognition could be responsible for
the subcellular localization of NPM, which although continuously
shuttling, is mostly enriched in the nucleolus. The speciﬁc ligands
of NPM within the nucleolus remain to be known, and besides pro-
teins, they could be either DNA or RNA (or both). Nevertheless, it
has been described that NPM preferentially binds G-rich DNA se-
quences that can form particular DNA structures known as G-
quadruplexes [12]. A recently presented structural model of a com-
plex between NPM C-terminal region and a G-quadruplex derived
from c-MYC promoter has shed light on the determinants of DNA
recognition by NPM [15]. Still, the interaction of functional, full-
length NPM needs to be explored. On the other hand, given that
the mentioned G4 structure might not be representative of nucle-
olar NPM ligands, the structural requirements of DNA to be recog-
nized should be understood in deeper detail.By contrast to previous studies, that have been carried out with
NPM C-terminal fragment [12,15], here we have characterized the
binding properties of full length pentameric NPM, which has ﬁve
potential DNA binding sites and a multidomain, ﬂexible structure,
for G4MYC and other G-rich oligonucleotides. We have found that
full length NPM binds G4MYC with similar afﬁnity to that de-
scribed for C70 fragment, suggesting that no other domain of
NPM participates in the interaction. Additionally, our data indicate
that NPM can employ its multiple DNA binding sites to associate
with several DNA molecules, which could help to more steadily lo-
cate the protein within the nucleolar environment.
S. Bañuelos et al. / FEBS Letters 587 (2013) 2254–2259 2259Structural information has established that NPM binds a mono-
molecular G-quadruplex [15]. Nevertheless, our data clearly show
that the protein readily recognizes also multimeric interchain
assemblies. Indeed, our results suggest that binding is not directly
correlated with the amount of monomeric G- quadruplex. NPM did
not show any signiﬁcant binding to c-MYC-derived oligos that
form only intramolecular G-quadruplexes (G4Pu22, G4Pu24I).
Although a C70:G4Pu24I complex has been shown by NMR [15],
the high concentrations required in this technique should have
overcome the otherwise low afﬁnity displayed by NPM. While G-
quadruplexes that may form in gene promoters are assumed to
be intramolecular [14], it cannot be excluded that intermolecular
G-quadruplexes could also form in the densely packed environ-
ment of cell nucleoli. On the other hand, NPM has been reported
to display RNAse activity [23], and therefore, might also bind G-
rich RNA in the nucleolus.
NPM mutations associated with AML result in unfolding of the
protein C-terminal domain and acquirement of a new NES [9]. It
has been shown that both features are jointly responsible of the
aberrant localization of mutant NPM to the cytoplasm of leukaemic
cells [10]. Herein we show that mutant NPM very poorly binds
DNA, probably due to its severe structural damage. Chiarella
et al. [16] have recently reported that NPM bearing AML mutations
completely loses its ability to bind G-quadruplex regions found in
ribosomal DNA. Although in our case, mutated NPM is found to
weakly bind DNA, our data provide independent conﬁrmation of
this ﬁnding and extend it to the full length protein. Nucleolar local-
ization of wild type NPM could depend, at least in part, on its
attachment to nucleic acids in that particular nuclear region.
Therefore, besides impairing other NPM functions that depend on
nucleic acid binding, AML-linked mutations could alter cellular
localization by disrupting the binding of the protein to nucleoli,
probably contributing to mislocalization.
Acknowledgements
Dr. José Antonio Rodríguez is acknowledged for critically read-
ing the manuscript. S.G.T. was a Visiting Senior Researcher, IKER-
BASQUE, Basque Foundation for Science.
References
[1] Lindström, M.S. (2011) NPM1/B23: a multifunctional chaperone in ribosome
biogenesis and chromatin remodeling. Biochem. Res. Int. 2011, 1–16.
[2] Grisendi, S., Mecucci, C., Falini, B. and Pandolﬁ, P.P. (2006) Nucleophosmin and
cancer. Nat. Rev. 6, 493–505.
[3] Lee, H.H., Kim, H.S., Kang, J.Y., Lee, B.I., Ha, J.Y., Yoon, H.J., Lim, S.O., Jung, G. and
Suh, S.W. (2007) Crystal structure of human nucleophosmin-core reveals
plasticity of the pentamer–pentamer interface. Proteins 69, 672–678.
[4] Grummitt, C.G., Townsley, F.M., Johnson, C.M., Warren, A.J. and Bycroft, M.
(2008) Structural consequences of nucleophosmin mutations in acute myeloid
leukemia. J. Biol. Chem. 283, 23326–23332.[5] Bolli, N. et al. (2007) Born to be exported: COOH-terminal nuclear export
signals of different strength ensure cytoplasmic accumulation of
nucleophosmin leukemic mutants. Cancer Res. 67, 6230–6237.
[6] Nishimura, Y., Ohkubo, T., Furuichi, Y. and Umekawa, H. (2002) Tryptophans
286 and 288 in the C-terminal region of protein B23.1 are important for its
nucleolar localization. Biosci. Biotechnol. Biochem. 66, 2239–2242.
[7] Emmott, E. and Hiscox, J.A. (2009) Nucleolar targeting: the hub of the matter.
EMBO Rep. 10, 231–238.
[8] Falini, B., Martelli, M.P., Bolli, N., Sportoletti, P., Liso, A., Tiacci, E. and Haferlach,
T. (2011) Acute myeloid leukemia with mutated nucleophosmin (NPM1): is it
a distinct entity? Blood 117, 1109–1120.
[9] Falini, B., Mecucci, C., et al. (2005) Cytoplasmic nucleophosmin in acute
myelogenous leukemia with a normal karyotype. N. Engl. J. Med. 352, 254–
266.
[10] Falini, B., Bolli, N., et al. (2006) Both carboxy-terminus NES motif and mutated
tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin
leukemic mutants in NPMc+ AML. Blood 107, 4514–4523.
[11] Wang, D., Baumann, A., Szebeni, A. and y Olson, M.O.J. (1994) The nucleic acid
binding activity of nucleolar protein B23.1 resides in its carboxyl-terminal
end. J. Biol. Chem. 269, 30994–30998.
[12] Federici, L., Arcovito, A., Scaglione, G.L., Scaloni, F., Lo Sterzo, C., Di Matteo, A.,
Falini, B., Giardina, B. and Brunori, M. (2010) Nucleophosmin C-terminal
leukemia-associated domain interacts with G-rich quadruplex forming DNA. J.
Biol. Chem. 285, 37138–37149.
[13] Burge, S., Parkinson, G.N., Hazel, P., Todd, A.K. and Neidle, S. (2006)
Quadruplex DNA: sequence, topology and structure. Nucleic Acids Res. 34,
5402–5415.
[14] Siddiqui-Jain, A., Grand, C.L., Bearss, D.J. and Hurley, L.H. (2002) Direct
evidence of a G-quadruplex in a promoter region and its targeting with a small
molecule to repress c-MYC transcription. Proc. Natl. Acad. Sci. USA 99, 11593–
11598.
[15] Gallo, A., Lo Sterzo, C., Mori, M., Di Matteo, A., Bertini, I., Banci, L., Brunori, M.
and Federici, L. (2012) Structure of nucleophosmin DNA-binding domain and
analysis of its complex with a G-quadruplex forming sequence from the c-MYC
promoter. J. Biol. Chem. 287, 26539–26548.
[16] Chiarella, S., De Cola, A., Scaglione, G.L., Carletti, E., Graziano, V., Barcaroli, D.,
Lo Sterzo, C., Di Matteo, A., Di Ilio, C., Flini, B., Arcovito, A., De Laurenzi, V. and
Federici, L. (2013) Nucleophosmin mutations alter its nucleolar localization by
impairing G-quadruplex binding at ribosomal DNA. Nucleic Acids Res. 41,
3228–3239.
[17] Dai, J., Carver, M., Hurley, L.H. and Yang, D. (2011) Solution structure of a 2:1
quindoline – c-MYC G-quadruplex: inights into G-quadruplex interactive
small molecule drug design. J. Am. Chem. Soc. 133, 17673–17680.
[18] Matilla, I., Alfonso, C., Rivas, G., Bolt, E.L., de la Cruz, F. and Cabezón, E. (2010)
The conjugative DNA translocase TrwB is a structure-speciﬁc DNA-binding
protein. J. Biol. Chem. 285, 17537–17544.
[19] Young, P. and Gautel, M. (2000) The interaction of titin and alpha-actinin is
controlled by a phospholipid-regulated intramolecular pseudoligand
mechanism. EMBO J. 19, 6331–6340.
[20] Itahana, K., Bhat, K.P., Jin, A., Itahana, Y., Hawke, D., Kobayashi, R. and Zhang, Y.
(2003) Tumor suppressor ARF degrades B23, a nucleolar protein involved in
ribosome biogenesis and cell proliferation. Mol. Cell 12, 1151–1164.
[21] Le, H.T., Miller, M.C., et al. (2012) Not all G-quadruplexes are created equally:
an investigation of the structural polymorphism of the c-Myc G-quadruplex
sequence and its interaction with the porphyrin TMPyP4. Org. Biomol. Chem.
10, 9393–9404.
[22] Taneva, S.G., Bañuelos, S. and Urbaneja, M.A. (2013) Thermodynamic
signatures of macromolecular complexes. Insights on the stability and
interactions of nucleoplasmin, a nuclear chaperone. In: ‘‘Applications of
calorimetry in a wide context – Differential scanning calorimetry, isothermal
titration calorimetry and microcalorimetry’’, Ed. In Tech, 153–182.
[23] Savkur, R.S. and Olson, M.O.J. (1998) Preferential cleavage in pre-ribosomal
RNA by protein B23 endoribonuclease. Nucleic Acids Res. 26, 4508–4515.
